Literature DB >> 19306643

[Endoscopic endonasal surgery for extrasellar tumors: case presentation and its future perspective].

Naokatsu Saeki1, Hisayuki Murai, Yuzo Hasegawa, Kentaro Horiguchi, Toyoyuki Hanazawa, Kazumasa Fukuda.   

Abstract

BACKGROUND AND OBJECTIVES: Endoscopic endonasal transsphenoidal surgery has been performed because of its advantages such as less invasive surgical management and more aggressive tumor removal of extrasellar lesions. In 2003, we began endoscope-assisting surgery. In 2006, we completely switched to the endoscopic endonasal approach without microscope or nasal specula. Today, we report endoscopic pituitary and skull base surgery in our institute. The endonasal approach via the sphenoid ostium was carried out without nasal specula. Postoperative nasal packing was basically not needed in such cases. In cases with meningiomas, craniopharyngiomas and giant pituitary adenomas, which needed intra-dural procedure, nasal procedures such as middle nasal conchotomy, posterior ethmoidectomy and skull base techniques such as optic canal decompression and removal of the planum sphenoidale were carried out to gain the wider operative field toward anterior skull base and lower clivus. Navigation and US-Doppler were essential. Angled endoscope attained more successful removal of tumor under direct visualization extending into the cavernous sinus (GH secreting ademomas) and lower clivus (chordoma). In the case of CSF (cerebrospinal fluid) leakage during operation, a newly designed balloon catheter was placed in the sphenoid sinus to fix the abdominal fat and fibrin glue at the leakage point. In recent cases, dural opening has been sutured. In the combination of such techniques, a lumbar drainage system to prevent postoperative CSF rhinorrhea became needless in many cases. Angled suction tips, single-shaft coagulation tools and slim and longer holding forceps, all of which were newly designed for endoscopic surgery, were essential for smoother procedure. Endonasal endoscopic pituitary surgery has resulted in less invasive transsphenoidal surgery since no postoperative nasal packing is needed and there is less dependency on lumbar drainage. Although better techniques to prevent postoperative CSF leakage needs to be developed, this endoscopic pituitary surgery will become more common and will become a standard procedure. Endoscopic skull base surgery has enabled more aggressive removal of extrasellar tumors with the aid of nasal and skull base techniques. This endoscopic skull base surgery is more highly specialized, needs special techniques and surgical training. Selection of patients is also important. This also needs collaboration with ENT (ear, nose, throat) doctors. To be acknowledged as a safe and successful procedure in skull base surgery, this complex procedure may be preferably carried out only in center hospitals, which deal with many patients with a skull base lesion.

Entities:  

Mesh:

Year:  2009        PMID: 19306643

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  4 in total

1.  Endoscopic endonasal skull base reconstruction using a nasal septal flap: surgical results and comparison with previous reconstructions.

Authors:  Kentaro Horiguchi; Hisayuki Murai; Yuzo Hasegawa; Toyoyuki Hanazawa; Iwao Yamakami; Naokatsu Saeki
Journal:  Neurosurg Rev       Date:  2010-03-02       Impact factor: 3.042

2.  Endoscopic endonasal trans-sphenoid surgery of pituitary adenoma.

Authors:  Yr Yadav; S Sachdev; V Parihar; H Namdev; Pr Bhatele
Journal:  J Neurosci Rural Pract       Date:  2012-09

3.  Endoscopic endonasal trans-sphenoid management of craniopharyngiomas.

Authors:  Yad Ram Yadav; Yadav Nishtha; Parihar Vijay; Ratre Shailendra; Kher Yatin
Journal:  Asian J Neurosurg       Date:  2015 Jan-Mar

4.  Characteristics and clinical outcomes in pituitary incidentalomas and non-incidental pituitary tumors treated with endoscopic transsphenoidal surgery.

Authors:  Yusuke Morinaga; Ichiro Abe; Kouhei Nii; Hayatsura Hanada; Yusuke Takemura; Yuichi Takashi; Kimiya Sakamoto; Ritsurou Inoue; Takafumi Mitsutake; Kunihisa Kobayashi; Toshio Higashi
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.